FDA 483 - Golden Shrimp Seafood Joint Stock Company - December 12, 2023

An FDA inspection of Golden Shrimp Seafood Joint Stock Company in Tuy Hoa, Vietnam, revealed deficiencies in their HACCP plan, specifically regarding histamine testing procedures. The firm's sampling methods for histamine were found to be inadequate, failing to focus on areas where histamine is more likely to be detected. These issues are significant, as the firm has a history of consumer complaints related to scombrotoxin poisoning and product recalls due to elevated histamine levels in their frozen yellowfin tuna.